"Redundancy" of endocannabinoid inactivation: New challenges and opportunities for pain control

ACS Chemical Neuroscience

Volumn 3, Issue 5, 2012, Pages 356-363

  Piscitelli, Fabiana ^a   Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

Author keywords

cannabinoid; COX 2; FAAH 1; MAGL; receptor; TRPA1; TRPV1

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; CANNABINOID RECEPTOR; CANNABIS; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; VANILLOID RECEPTOR 1;

ALTERNATIVE RNA SPLICING; CELLULAR DISTRIBUTION; CHEMICAL STRUCTURE; CONFERENCE PAPER; HUMAN; HYDROLYSIS; INFLAMMATION; NONHUMAN; OXIDATION; PAIN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

CANNABINOID; COX-2; FAAH-1; MAGL; RECEPTOR; TRPA1; TRPV1;

ANALGESICS; ANIMALS; ENDOCANNABINOIDS; HUMANS; METABOLIC NETWORKS AND PATHWAYS; PAIN; PAIN MANAGEMENT;

CANNABIS;

EID: 84862077780     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/cn300015x     Document Type: Conference Paper

References (74)

1. Hosking, R. D. and Zajicek, J. P. (2008) Therapeutic potential of cannabis in pain medicine Br. J. Anaesth. 101, 59-68 (Pubitemid 351881914)
2. Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., and Bonner, T. I. (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA Nature 346, 561-564
3. Munro, S., Thomas, K. L., and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids Nature 365, 61-65 (Pubitemid 23305569)
4. Nagarkatti, P., Pandey, R., Rieder, S. A., Hegde, V. L., and Nagarkatti, M. (2009) Cannabinoids as novel anti-inflammatory drugs Future Med. Chem. 1, 1333-1349
5. Di Marzo, V. and Fontana, A. (1995) Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone' Prostaglandins, Leukotrienes Essent. Fatty Acids 53, 1-11
6. Devane, W. A., Breuer, A., Sheskin, T., Jarbe, T. U., Eisen, M. S., and Mechoulam, R. (1992) A novel probe for the cannabinoid receptor J. Med. Chem. 35, 2065-2069
7. Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., Gopher, A., Almog, S., Martin, B. R., and Compton, D. R. 1995, Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors Biochem. Pharmacol. 50, 83-90
8. Sugiura, T., Kondo, S., Sukagawa, A., Nakane, S., Shinoda, A., Itoh, K., Yamashita, A., and Waku, K. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain Biochem. Biophys. Res. Commun. 215, 89-97
9. Di Marzo, V. (2008) Targeting the endocannabinoid system: to enhance or reduce? Nat. Rev. Drug Discovery 7, 438-455 (Pubitemid 351649182)
10. Mitrirattanakul, S., Ramakul, N., Guerrero, A. V., Matsuka, Y., Ono, T., Iwase, H., Mackie, K., Faull, K. F., and Spigelman, I. (2006) Site-specific increases in peripheral cannabinoid receptors and their endogenous ligands in a model of neuropathic pain Pain 126, 102-114 (Pubitemid 44781351)
11. Petrosino, S., Palazzo, E., de Novellis, V., Bisogno, T., Rossi, F., Maione, S., and Di Marzo, V. (2007) Changes in spinal and supraspinal endocannabinoid levels in neuropathic rats Neuropharmacology 52, 415-422 (Pubitemid 46127787)
12. Agarwal, N., Pacher, P., Tegeder, I., Amaya, F., Constantin, C. E., Brenner, G. J., Rubino, T., Michalski, C. W., Marsicano, G., Monory, K., Mackie, K., Marian, C., Batkai, S., Parolaro, D., Fischer, M. J., Reeh, P., Kunos, G., Kress, M., Lutz, B., Woolf, C. J., and Kuner, R. (2007) Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors Nat. Neurosci. 10, 870-879 (Pubitemid 47013432)
13. Richardson, D., Pearson, R. G., Kurian, N., Latif, M. L., Garle, M. J., Barrett, D. A., Kendall, D. A., Scammell, B. E., Reeve, A. J., and Chapman, V. (2008) Characterisation of the cannabinoid receptor system in synovial tissue and fluid in patients with osteoarthritis and rheumatoid arthritis Arthritis Res. Ther. 10, R43
14. Costa, B., Bettoni, I., Petrosino, S., Comelli, F., Giagnoni, G., and Di Marzo, V. (2010) The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl-serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice Pharmacol. Res. 61, 537-546
15. Giordano, C., Cristino, L., Luongo, L., Siniscalco, D., Petrosino, S., Piscitelli, F., Marabese, I., Gatta, L., Rossi, F., Imperatore, R., Palazzo, E., de Novellis, V., Di Marzo, V., and Maione, S. TRPV1-Dependent and-Independent Alterations in the Limbic Cortex of Neuropathic Mice: Impact on Glial Caspases and Pain Perception. Cereb. Cortex 2011, not supplied.
16. Alvarez-Jaimes, L. J. and Palmer, J. A. The Role of Endocannabinoids in Pain Modulation and the Therapeutic Potential of Inhibiting their Enzymatic Degradation. Curr. Pharm. Biotechnol. 2011, not supplied.
17. Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., and Gilula, N. B. (1996) Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384, 83-87 (Pubitemid 26374593)
18. Hansen, H. S. (2010) Palmitoylethanolamide and other anandamide congeners. Proposed role in the diseased brain Exp. Neurol. 224, 48-55
19. Fu, J., Gaetani, S., Oveisi, F., Lo Verme, J., Serrano, A., Rodriguez De Fonseca, F., Rosengarth, A., Luecke, H., Di Giacomo, B., Tarzia, G., and Piomelli, D. (2003) Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha Nature 425, 90-93 (Pubitemid 37101723)
20. Movahed, P., Jonsson, B. A., Birnir, B., Wingstrand, J. A., Jorgensen, T. D., Ermund, A., Sterner, O., Zygmunt, P. M., and Hogestatt, E. D. (2005) Endogenous unsaturated C18 N-acylethanolamines are vanilloid receptor (TRPV1) agonists J. Biol. Chem. 280, 38496-38504 (Pubitemid 43853748)
21. Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H., Sorgard, M., Di Marzo, V., Julius, D., and Hogestatt, E. D. (1999) Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400, 452-457 (Pubitemid 29361798)
22. Wei, B. Q., Mikkelsen, T. S., McKinney, M. K., Lander, E. S., and Cravatt, B. F. (2006) A second fatty acid amide hydrolase with variable distribution among placental mammals J. Biol. Chem. 281, 36569-36578 (Pubitemid 46049797)
23. Petrosino, S., Iuvone, T., and Di Marzo, V. (2010) N-palmitoyl- ethanolamine: Biochemistry and new therapeutic opportunities Biochimie 92, 724-727
24. Ueda, N., Yamanaka, K., and Yamamoto, S. (2001) Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance J. Biol. Chem. 276, 35552-35557
25. Sigel, E., Baur, R., Racz, I., Marazzi, J., Smart, T. G., Zimmer, A., and Gertsch, J. (2011) The major central endocannabinoid directly acts at GABAA receptors Proc. Natl. Acad. Sci. U.S.A. 108, 18150-18155
26. Dinh, T. P., Freund, T. F., and Piomelli, D. (2002) A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation Chem. Phys. Lipids 121, 149-158 (Pubitemid 36044549)
27. Blankman, J. L., Simon, G. M., and Cravatt, B. F. (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2- arachidonoylglycerol Chem. Biol. 14, 1347-1356 (Pubitemid 350257008)
28. Gammon, C. M., Allen, A. C., and Morell, P. (1989) Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglion neurons J. Neurochem. 53, 95-101 (Pubitemid 19158114)
29. Nomura, D. K., Lombardi, D. P., Chang, J. W., Niessen, S., Ward, A. M., Long, J. Z., Hoover, H. H., and Cravatt, B. F. (2011) Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer Chem. Biol. 18, 846-856
30. Kozak, K. R. and Marnett, L. J. (2002) Oxidative metabolism of endocannabinoids Prostaglandins, Leukotrienes Essent. Fatty Acids 66, 211-220 (Pubitemid 34743596)
31. Snider, N. T., Walker, V. J., and Hollenberg, P. F. (2010) Oxidation of the endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxygenases: physiological and pharmacological implications Pharmacol. Rev. 62, 136-154
32. Kozak, K. R., Crews, B. C., Morrow, J. D., Wang, L. H., Ma, Y. H., Weinander, R., Jakobsson, P. J., and Marnett, L. J. (2002) Metabolism of the endocannabinoids, 2-arachidonylglycerol and anandamide, into prostaglandin, thromboxane, and prostacyclin glycerol esters and ethanolamides J. Biol. Chem. 277, 44877-44885 (Pubitemid 36159083)
33. Woodward, D. F., Carling, R. W., Cornell, C. L., Fliri, H. G., Martos, J. L., Pettit, S. N., Liang, Y., and Wang, J. W. (2008) The pharmacology and therapeutic relevance of endocannabinoid derived cyclo-oxygenase (COX)-2 products Pharmacol. Ther. 120, 71-80
34. De Petrocellis, L., Bisogno, T., Maccarrone, M., Davis, J. B., Finazzi-Agro, A., and Di Marzo, V. (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism J. Biol. Chem. 276, 12856-12863
35. De Petrocellis, L., Deva, R., Mainieri, F., Schaefer, M., Bisogno, T., Ciccoli, R., Ligresti, A., Hill, K., Nigam, S., Appendino, G., and Di Marzo, V. (2009) Chemical synthesis, pharmacological characterization, and possible formation in unicellular fungi of 3-hydroxy-anandamide J. Lipid Res. 50, 658-666
36. Edgemond, W. S., Hillard, C. J., Falck, J. R., Kearn, C. S., and Campbell, W. B. (1998) Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): their affinities for cannabinoid receptors and pathways of inactivation Mol. Pharmacol. 54, 180-188 (Pubitemid 28337601)
37. Matias, I., Chen, J., De Petrocellis, L., Bisogno, T., Ligresti, A., Fezza, F., Krauss, A. H., Shi, L., Protzman, C. E., Li, C., Liang, Y., Nieves, A. L., Kedzie, K. M., Burk, R. M., Di Marzo, V., and Woodward, D. F. (2004) Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism J. Pharmacol. Exp. Ther. 309, 745-757 (Pubitemid 38542631)
38. Nirodi, C. S., Crews, B. C., Kozak, K. R., Morrow, J. D., and Marnett, L. J. (2004) The glyceryl ester of prostaglandin E2 mobilizes calcium and activates signal transduction in RAW264.7 cells Proc. Natl. Acad. Sci. U.S.A. 101, 1840-1845 (Pubitemid 38228978)
39. Hu, S. S., Bradshaw, H. B., Chen, J. S., Tan, B., and Walker, J. M. (2008) Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity Br. J. Pharmacol. 153, 1538-1549 (Pubitemid 351481525)
40. Hogestatt, E. D., Jonsson, B. A., Ermund, A., Andersson, D. A., Bjork, H., Alexander, J. P., Cravatt, B. F., Basbaum, A. I., and Zygmunt, P. M. (2005) Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system J. Biol. Chem. 280, 31405-31412 (Pubitemid 41291881)
41. Mukhopadhyay, B., Cinar, R., Yin, S., Liu, J., Tam, J., Godlewski, G., Harvey-White, J., Mordi, I., Cravatt, B. F., Lotersztajn, S., Gao, B., Yuan, Q., Schuebel, K., Goldman, D., and Kunos, G. (2011) Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver Proc. Natl. Acad. Sci. U.S.A. 108, 6323-6328
42. Beltramo, M., Stella, N., Calignano, A., Lin, S. Y., Makriyannis, A., and Piomelli, D. (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition Science 277, 1094-1097 (Pubitemid 27371630)
43. De Petrocellis, L., Bisogno, T., Davis, J. B., Pertwee, R. G., and Di Marzo, V. (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity FEBS Lett. 483, 52-56
44. Fowler, C. J., Tiger, G., Ligresti, A., Lopez-Rodriguez, M. L., and Di Marzo, V. (2004) Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis- a difficult issue to handle Eur. J. Pharmacol. 492, 1-11 (Pubitemid 38624415)
45. Zygmunt, P. M., Chuang, H., Movahed, P., Julius, D., and Hogestatt, E. D. (2000) The anandamide transport inhibitor AM404 activates vanilloid receptors Eur. J. Pharmacol. 396, 39-42 (Pubitemid 30261557)
46. Dani, M., Guindon, J., Lambert, C., and Beaulieu, P. (2007) The local antinociceptive effects of paracetamol in neuropathic pain are mediated by cannabinoid receptors Eur. J. Pharmacol. 573, 214-215 (Pubitemid 47464223)
47. Mallet, C., Barriere, D. A., Ermund, A., Jonsson, B. A., Eschalier, A., Zygmunt, P. M., and Hogestatt, E. D. (2010) TRPV1 in brain is involved in acetaminophen-induced antinociception PLoS One 5, xxx-xxx
48. Mallet, C., Daulhac, L., Bonnefont, J., Ledent, C., Etienne, M., Chapuy, E., Libert, F., and Eschalier, A. (2008) Endocannabinoid and serotonergic systems are needed for acetaminophen-induced analgesia Pain 139, 190-200
49. Ottani, A., Leone, S., Sandrini, M., Ferrari, A., and Bertolini, A. (2006) The analgesic activity of paracetamol is prevented by the blockade of cannabinoid CB1 receptors Eur. J. Pharmacol. 531, 280-281 (Pubitemid 43202247)
50. Andersson, D. A., Gentry, C., Alenmyr, L., Killander, D., Lewis, S. E., Andersson, A., Bucher, B., Galzi, J. L., Sterner, O., Bevan, S., Hogestatt, E. D., and Zygmunt, P. M. (2011) TRPA1 mediates spinal antinociception induced by acetaminophen and the cannabinoid Delta(9)-tetrahydrocannabiorcol Nat. Commun. 2, 551
51. Rogosch, T., Sinning, C., Podlewski, A., Watzer, B., Schlosburg, J., Lichtman, A. H., Cascio, M. G., Bisogno, T., Di Marzo, V., Nusing, R., and Imming, P. (2012) Novel bioactive metabolites of dipyrone (metamizol) Bioorg. Med. Chem. 20, 101-107
52. Sinning, C., Watzer, B., De Petrocellis, L., Di Marzo, V., and Imming, P. (2008) Dopamides, vanillylamides, ethanolamides, and arachidonic acid amides of anti-inflammatory and analgesic drug substances as TRPV1 ligands ChemMedChem 3, 1956-1964
53. Escobar, W., Ramirez, K., Avila, C., Limongi, R., Vanegas, H., and Vazquez, E. (2011) Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats., Eur. J. Pain, published online Dec 17, 2011, DOI: 10.1002/j.1532-2149.2011.00057.x.
54. Duggan, K. C., Hermanson, D. J., Musee, J., Prusakiewicz, J. J., Scheib, J. L., Carter, B. D., Banerjee, S., Oates, J. A., and Marnett, L. J. (2011) R)-Profens are substrate-selective inhibitors of endocannabinoid oxygenation by COX-2 Nat. Chem. Biol. 7, 803-809
55. Gatta, L., Piscitelli, F., Giordano, C., Boccella, S., Lichtman, A. H., Maione, S., and Di Marzo, V. Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability. PLoS One 2011, in press.
56. Sagredo, O., Pazos, R., Bisogno, T., Piscitelli, F., Petrosino, S., Valdeolivas, S., Hernández, M., Di Marzo, V., and Fernández-Ruiz, J. (2011) Potential oxidation of 2-AG by COX-2 enhances malonate toxicity in the striatum: relevance for cannabinoid treatments in Huntington's disease, IACM 6th Conference on Cannabinoids in Medicine and 5th European Workshop on Cannabinoid Research.
57. Kinsey, S. G., Nomura, D. K., O'Neal, S. T., Long, J. Z., Mahadevan, A., Cravatt, B. F., Grider, J. R., and Lichtman, A. H. (2011) Inhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice J. Pharmacol. Exp. Ther. 338, 795-802
58. Bisogno, T., Melck, D., De Petrocellis, L., Bobrov, M., Gretskaya, N. M., Bezuglov, V. V., Sitachitta, N., Gerwick, W. H., and Di Marzo, V. (1998) Arachidonoylserotonin and other novel inhibitors of fatty acid amide hydrolase Biochem. Biophys. Res. Commun. 248, 515-522 (Pubitemid 28404452)
59. Maione, S., De Petrocellis, L., de Novellis, V., Moriello, A. S., Petrosino, S., Palazzo, E., Rossi, F. S., Woodward, D. F., and Di Marzo, V. (2007) Analgesic actions of N-arachidonoyl-serotonin, a fatty acid amide hydrolase inhibitor with antagonistic activity at vanilloid TRPV1 receptors Br. J. Pharmacol. 150, 766-781 (Pubitemid 46440215)
60. Ortar, G., Cascio, M. G., De Petrocellis, L., Morera, E., Rossi, F., Schiano-Moriello, A., Nalli, M., de Novellis, V., Woodward, D. F., Maione, S., and Di Marzo, V. (2007) New N-arachidonoylserotonin analogues with potential 'dual' mechanism of action against pain J. Med. Chem. 50, 6554-6569 (Pubitemid 350309095)
61. Morera, E., De Petrocellis, L., Morera, L., Moriello, A. S., Ligresti, A., Nalli, M., Woodward, D. F., Di Marzo, V., and Ortar, G. (2009) Synthesis and biological evaluation of piperazinyl carbamates and ureas as fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channel dual ligands Bioorg. Med. Chem. Lett. 19, 6806-6809
62. De Petrocellis, L., Ligresti, A., Moriello, A. S., Allara, M., Bisogno, T., Petrosino, S., Stott, C. G., and Di Marzo, V. (2011) Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes Br. J. Pharmacol. 163, 1479-1494
63. Carrier, E. J., Auchampach, J. A., and Hillard, C. J. (2006) Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression Proc. Natl. Acad. Sci. U.S.A. 103, 7895-7900
64. Costa, B., Giagnoni, G., Franke, C., Trovato, A. E., and Colleoni, M. (2004) Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation Br. J. Pharmacol. 143, 247-250 (Pubitemid 39315144)
65. Costa, B., Trovato, A. E., Comelli, F., Giagnoni, G., and Colleoni, M. (2007) The non-psychoactive cannabis constituent cannabidiol is an orally effective therapeutic agent in rat chronic inflammatory and neuropathic pain Eur. J. Pharmacol. 556, 75-83 (Pubitemid 46074009)
66. Maione, S., Piscitelli, F., Gatta, L., Vita, D., De Petrocellis, L., Palazzo, E., de Novellis, V., and Di Marzo, V. (2011) Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action Br. J. Pharmacol. 162, 584-596
67. Maccarrone, M., Dainese, E., and Oddi, S. (2010) Intracellular trafficking of anandamide: new concepts for signaling Trends Biochem. Sci. 35, 601-608
68. Hillard, C. J., Shi, L., Tuniki, V. R., Falck, J. R., and Campbell, W. B. (2007) Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase J. Mol. Neurosci. 33, 18-24 (Pubitemid 47574953)
69. Maione, S., Morera, E., Marabese, I., Ligresti, A., Luongo, L., Ortar, G., and Di Marzo, V. (2008) Antinociceptive effects of tetrazole inhibitors of endocannabinoid inactivation: cannabinoid and non-cannabinoid receptor-mediated mechanisms Br. J. Pharmacol. 155, 775-782
70. Fu, J., Bottegoni, G., Sasso, O., Bertorelli, R., Rocchia, W., Masetti, M., Guijarro, A., Lodola, A., Armirotti, A., Garau, G., Bandiera, T., Reggiani, A., Mor, M., Cavalli, A., and Piomelli, D. (2012) A catalytically silent FAAH-1 variant drives anandamide transport in neurons Nat. Neurosci. 15, 64-69
71. Long, J. Z., Nomura, D. K., Vann, R. E., Walentiny, D. M., Booker, L., Jin, X., Burston, J. J., Sim-Selley, L. J., Lichtman, A. H., Wiley, J. L., and Cravatt, B. F. (2009) Dual blockade of FAAH and MAGL identifies behavioral processes regulated by endocannabinoid crosstalk in vivo Proc. Natl. Acad. Sci. U.S.A. 106, 20270-20275
72. de Lago, E., Petrosino, S., Valenti, M., Morera, E., Ortega-Gutierrez, S., Fernandez-Ruiz, J., and Di Marzo, V. (2005) Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels Biochem. Pharmacol. 70, 446-452 (Pubitemid 40905116)
73. Kaczocha, M., Vivieca, S., Sun, J., Glaser, S. T., and Deutsch, D. G. (2012) Fatty acid binding proteins transport N-acylethanolamines to nuclear receptors and are targets of endocannabinoid transport inhibitors J. Biol. Chem. 287, 3415-3424
74. Ligresti, A., De Petrocellis, L., Hernan Perez de la Ossa, D., Aberturas, R., Cristino, L., Moriello, A. S., Finizio, A., Gil, M. E., Torres, A. I., Molpeceres, J., and Di Marzo, V. (2010) Exploiting nanotechnologies and TRPV1 channels to investigate the putative anandamide membrane transporter PLoS One 5, e10239